Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Starpharma Holdings Announces Being Awarded DEP Grant

09 Oct 2017  |  13:23:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Starpharma and Peter Mac Cancer Centre awarded DEP Grant

Starpharma Holdings and Peter MacCallum Cancer Centre have been awarded a further Federal Government Innovation Connections grant to support innovative research within the Company's DEP oncology program. The Company's proprietary DEP dendrimer platform improved efficacy and reduces off-target toxicity to improve therapeutic outcomes for cancer patients. The oncology therapeutic agents are commonly used in combination to achieve optimal impact on cancer cells. This $50,000 of funding will be used to assess DEP candidates in combination with the existing therapeutic agents.

Please click here for full details

See more ASX300 News Announcements